These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9758345)

  • 1. Ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver diseases in bone marrow transplant patients.
    Picardi M; De Rosa G; Muretto P; Pezzullo L; Raiola A; Rotoli B
    Bone Marrow Transplant; 1998 Sep; 22(6):571-3. PubMed ID: 9758345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients.
    Picardi M; Muretto P; De Rosa G; Selleri C; De Renzo A; Persico M; Rotoli B
    Haematologica; 2002 Jun; 87(6):652-7. PubMed ID: 12031923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.
    Iqbal M; Creger RJ; Fox RM; Cooper BW; Jacobs G; Stellato TA; Lazarus HM
    Bone Marrow Transplant; 1996 Apr; 17(4):655-62. PubMed ID: 8722371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of liver biopsy in bone marrow transplant patients.
    Chahal P; Levy C; Litzow MR; Lindor KD
    J Gastroenterol Hepatol; 2008 Feb; 23(2):222-5. PubMed ID: 18289356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver dysfunction in the early post-bone marrow transplant period.
    Storek J
    Cas Lek Cesk; 1996 May; 135(10):295-8. PubMed ID: 8697490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of bone marrow transplantation.
    Bombi JA; Palou J; Bruguera M; Feliu E; Martin-Ortega E; Rozman C; Cardesa A
    Semin Diagn Pathol; 1992 Aug; 9(3):220-31. PubMed ID: 1523360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of skin biopsies in bone marrow transplant recipients.
    Hepburn NC; McLaren KM; Turner ML; Beveridge GW
    Q J Med; 1993 Nov; 86(11):715-7. PubMed ID: 8265771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy.
    Wang JY; Chang YL; Lee LN; Chen JH; Tang JL; Yang PC; Lee YC
    Ann Thorac Surg; 2004 Jul; 78(1):267-72. PubMed ID: 15223441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle biopsy of the liver. A critique of four currently available methods.
    Babb RR; Jackman RJ
    West J Med; 1989 Jan; 150(1):39-42. PubMed ID: 2660406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GI complications in pediatric patients post-BMT.
    Barker CC; Anderson RA; Sauve RS; Butzner JD
    Bone Marrow Transplant; 2005 Jul; 36(1):51-8. PubMed ID: 15908980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic yield of transjugular liver biopsy samples to evaluate for infectious etiology of liver dysfunction in bone marrow transplant recipients.
    Nadolski G; Mondschein JI; Shlansky-Goldberg RD; Stavropoulos SW; Soulen MC; Dagli MS; Clark TW; Trerotola SO
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):471-5. PubMed ID: 23760757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular liver biopsy in BMT.
    Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies MD; García-Pagán JC; Martí JM; Bosch J
    Bone Marrow Transplant; 1993 Jan; 11(1):21-6. PubMed ID: 8431707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
    Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
    Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE; McKee PH; Nghiem P
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.